Virtus ETF Advisers LLC Eq Rx, Inc. Transaction History

Virtus ETF Advisers LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$1.66 - $2.31 $9,025 - $12,559	-5,437 Reduced 9.05%	54,639 $121,000
Q2 2023 Aug 14, 2023	BUY	$1.61 - $1.96 $29,966 - $36,481	18,613 Added 44.89%	60,076 $111,000
Q1 2023 May 15, 2023	SELL	$1.8 - $2.83 $28,695 - $45,115	-15,942 Reduced 27.77%	41,463 $80,000
Q4 2022 Feb 14, 2023	BUY	$2.05 - $5.5 $61,317 - $164,510	29,911 Added 108.79%	57,405 $141,000
Q3 2022 Nov 14, 2022	BUY	$0.94 - $5.99 $192 - $1,227	205 Added 0.75%	27,494 $136,000
Q2 2022 Aug 12, 2022	BUY	$3.2 - $5.69 $87,324 - $155,274	27,289 New	27,289 $128,000

67.8M

Ticker EQRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 448,140,992
Description
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.